Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neurocognitive Outcome as a Metric for Evaluating Therapeutic Intervention and Treatment Mechanisms in Congenital Central Hypoventilation Syndrome (CCHS): A Multi-Site Study Using The NIH Toolbox

NCT03568669 is registered in ClinicalTrials.gov with Ilya Khaytin as lead sponsor.

NCT NCT03568669
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03568669 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neurocognitive Outcome as a Metric for Evaluating Therapeutic Intervention and Treatment Mechanisms in Congenital Central Hypoventilation Syndrome (CCHS): A Multi-Site Study Using The NIH Toolbox
Lead sponsor
Ilya Khaytin
Phase
Observational
Overall status
Recruiting
Start date
January 31, 2016
Completion date
December 31, 2035
Enrollment
1,000 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

cchs, cchs with hirschsprung disease, cchs with neural crest tumor, cchs with neuroblastoma, congenital central hypoventilation, congenital central hypoventilation syndrome